Last reviewed · How we verify

Kali bichromicum 10-60 (C30) — Competitive Intelligence Brief

Kali bichromicum 10-60 (C30) (Kali bichromicum 10-60 (C30)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 3 Small molecule Live · refreshed every 30 min

Target snapshot

Kali bichromicum 10-60 (C30) (Kali bichromicum 10-60 (C30)) — Shaare Zedek Medical Center. Kali bichromicum is a homeopathic potentized preparation of potassium dichromate used in homeopathic medicine, with no established conventional pharmacological mechanism.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Kali bichromicum 10-60 (C30) TARGET Kali bichromicum 10-60 (C30) Shaare Zedek Medical Center phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Kali bichromicum 10-60 (C30) — Competitive Intelligence Brief. https://druglandscape.com/ci/kali-bichromicum-10-60-c30. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: